Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Liver Neoplasms"" wg kryterium: Temat


Tytuł:
Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model.
Autorzy:
Guo R; Department of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Middle Zhi-jiang Road, Shanghai, 200071, People's Republic of China.
Lu F; Department of Radiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Lin J; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.; Shanghai Institute of Medical Imaging, Shanghai, 200032, People's Republic of China.
Fu C; MR Application Development, Siemens Shenzhen Magnetic Resonance Ltd, Shenzhen, 518057, People's Republic of China.
Liu M; MR scientific Marketing, Diagnostic Imaging, Siemens Healthineers Ltd, Shanghai, 201318, People's Republic of China.
Yang S; Department of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Middle Zhi-jiang Road, Shanghai, 200071, People's Republic of China. caddie_.
Pokaż więcej
Źródło:
European radiology experimental [Eur Radiol Exp] 2024 Mar 12; Vol. 8 (1), pp. 43. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/drug therapy
Bufanolides*
Humans ; Animals ; Mice ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; Mice, Nude
Czasopismo naukowe
Tytuł:
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial.
Autorzy:
Coffman-D'Annibale K; Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Myojin Y; Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Monge C; Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Xie C; Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Hrones DM; Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Wood BJ; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center & Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA.
Levy EB; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center & Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA.
Kleiner D; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Figg WD; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Steinberg SM; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Redd B; Radiology and Imaging Sciences, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Greten TF; Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA .; Liver Cancer Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jan 06; Vol. 12 (1). Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Adult ; Humans ; Female ; Middle Aged ; Male ; Nivolumab/therapeutic use ; CD8-Positive T-Lymphocytes ; Leukocytes, Mononuclear ; Angiogenesis Inhibitors ; Microsatellite Repeats ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy.
Autorzy:
Stocker D; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. .
King MJ; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Homsi ME; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Gnerre J; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Marinelli B; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Division of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Wurnig M; Institute of Radiology, Spital Lachen AG, Lachen, Switzerland.
Schwartz M; Recanati Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kim E; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Taouli B; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Jan; Vol. 34 (1), pp. 475-484. Date of Electronic Publication: 2023 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/radiotherapy
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/radiotherapy
Liver Neoplasms*/surgery
Humans ; Aged ; Retrospective Studies ; Pneumonectomy ; Magnetic Resonance Imaging/methods ; Sensitivity and Specificity ; Contrast Media
Czasopismo naukowe
Tytuł:
Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
Autorzy:
Cha DI; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Kang TW; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea. .
Jeong WK; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Kim JM; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Choi GS; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Joh JW; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Yi NJ; Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
Ahn SH; Department of Mathematics, Ajou University, Suwon, Republic of Korea.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Jan; Vol. 34 (1), pp. 498-508. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Transplantation*
Gadolinium DTPA*
Male ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Magnetic Resonance Imaging ; Retrospective Studies ; Prognosis ; Neoplasm Invasiveness/pathology
Czasopismo naukowe
Tytuł:
Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.
Autorzy:
Wang Y; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun X; Department of Hepatobiliary and Pancreatic Surgery, Huzhou Central Hospital, Huzhou, China.
Chen C; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ge H; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun J; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of General Surgery, Ningbo Fourth Hospital, Ningbo, China.
Li E; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Cai Z; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Fu Q; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun X; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wu J; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ye M; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Cao W; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen Q; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wei X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Han X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun K; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yan Q; Department of Hepatobiliary and Pancreatic Surgery, Huzhou Central Hospital, Huzhou, China.
Huang W; Department of Pathology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wu L; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zeng Y; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Zhang Q; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang University Cancer Center, Hangzhou, China; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, China. Electronic address: .
Liang T; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang University Cancer Center, Hangzhou, China; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, China. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2024 Mar 31; Vol. 585, pp. 216654. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Humans ; Retrospective Studies ; Prospective Studies ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Tytuł:
FGF19-Based Mini Probe Targeting FGFR4 for Diagnosis and Surgical Navigation of Hepatocellular Carcinoma.
Autorzy:
Cai J; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Lian C; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.; Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, International Campus, Zhejiang University, Haining 314400, China.
Lu Z; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Shang Q; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Wang L; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Han Z; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Gu Y; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Pokaż więcej
Źródło:
Journal of medicinal chemistry [J Med Chem] 2024 Mar 14; Vol. 67 (5), pp. 3764-3777. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnosis
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Surgery, Computer-Assisted*
Humans ; Receptor, Fibroblast Growth Factor, Type 4 ; Fibroblast Growth Factors ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Knockdown of ribosome RNA processing protein 15 suppresses migration of hepatocellular carcinoma through inhibiting PATZ1-associated LAMC2/FAK pathway.
Autorzy:
Pan T; Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, The First Affiliated Hospital of Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Li J; Department of Liver and Gall Surgery, The Third Affiliated Hospital of Wenzhou Medical University, 325200, Wenzhou, Zhejiang, China.
Zhang O; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Zhu Y; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Zhou H; Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, The First Affiliated Hospital of Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Ma M; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Yu Y; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Lyu J; Department of Infectious Diseases, Lishui People's Hospital, 323000, Lishui, Zhejiang, China.
Chen Y; Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, The First Affiliated Hospital of Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China. .
Xu L; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 12; Vol. 24 (1), pp. 334. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
RNA Processing, Post-Transcriptional*
Ribosomal Proteins*/genetics
Ribosomal Proteins*/metabolism
Animals ; Mice ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation ; Epithelial-Mesenchymal Transition/genetics ; Focal Adhesion Protein-Tyrosine Kinases/genetics ; Focal Adhesion Protein-Tyrosine Kinases/metabolism ; Gene Expression Regulation, Neoplastic ; NF-kappa B/metabolism ; Ribosomes/metabolism ; Ribosomes/pathology ; Transcription Factors/genetics
Czasopismo naukowe
Tytuł:
Decreased mebrofenin uptake in patients with non-colorectal liver tumors requiring liver volume augmentation-a single-center analysis.
Autorzy:
Fard-Aghaie MH; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. .
Stern L; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Ghadban T; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Apostolova I; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Lehnert W; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Klutmann S; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Hackert T; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Izbicki JR; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Li J; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
von Kroge PH; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Heumann A; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Pokaż więcej
Źródło:
Langenbeck's archives of surgery [Langenbecks Arch Surg] 2024 Mar 11; Vol. 409 (1), pp. 92. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Failure*/etiology
Colorectal Neoplasms*/diagnostic imaging
Colorectal Neoplasms*/surgery
Colorectal Neoplasms*/complications
Aniline Compounds*
Glycine*
Humans ; Radiopharmaceuticals ; Liver/diagnostic imaging ; Liver/surgery ; Hepatectomy/adverse effects ; Retrospective Studies ; Postoperative Complications
Czasopismo naukowe
Tytuł:
The most impactful findings on liver cancer in 2023.
Autorzy:
Lee J; Department of Pathology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Department of Molecular Biology, School of Biological Sciences, University of California San Diego, La Jolla, California, USA.
Hanley KL; Department of Pathology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Department of Molecular Biology, School of Biological Sciences, University of California San Diego, La Jolla, California, USA.
Feng GS; Department of Pathology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Department of Molecular Biology, School of Biological Sciences, University of California San Diego, La Jolla, California, USA.
Pokaż więcej
Źródło:
Hepatology communications [Hepatol Commun] 2024 Mar 11; Vol. 8 (4). Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/diagnosis
Liver Neoplasms*/genetics
Liver Neoplasms*/therapy
Humans
Czasopismo naukowe
Tytuł:
Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway.
Autorzy:
Wang R; National Key Clinical Specialty (General Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.; Wenzhou Medical University, Wenzhou, 325000, China.
Li R; Wenzhou Medical University, Wenzhou, 325000, China.
Yang H; Wenzhou Medical University, Wenzhou, 325000, China.
Chen X; National Key Clinical Specialty (General Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.; Wenzhou Medical University, Wenzhou, 325000, China.
Wu L; Wenzhou Medical University, Wenzhou, 325000, China.
Zheng X; Wenzhou Medical University, Wenzhou, 325000, China. .
Jin Y; National Key Clinical Specialty (General Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Mar 09; Vol. 150 (3), pp. 117. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Proto-Oncogene Proteins c-akt*/metabolism
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Chalcones*
Humans ; Animals ; Mice ; Phosphatidylinositol 3-Kinases/metabolism ; Cell Line, Tumor ; Signal Transduction ; Apoptosis ; Cell Proliferation ; Cell Movement/genetics
Czasopismo naukowe
Tytuł:
Safety and Feasibility of Laparoscopic Liver Resection with the Clamp-Crush Method Using the BiSect.
Autorzy:
Yoshioka M; Department of Gastroenterological Surgery, Nippon Medical School Musashi Kosugi Hospital.
Shimizu T; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital.
Ueda J; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital.
Kawashima M; Department of Gastroenterological Surgery, Nippon Medical School Chiba Hokusoh Hospital.
Irie T; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital.
Haruna T; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital.
Ohno T; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital.
Kawano Y; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital.
Mizuguchi Y; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital.
Matsushita A; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital.
Taniai N; Department of Gastroenterological Surgery, Nippon Medical School Musashi Kosugi Hospital.
Yoshida H; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital.
Pokaż więcej
Źródło:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2024 Mar 09; Vol. 91 (1), pp. 108-113. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Laparoscopy*/methods
Carcinoma, Hepatocellular*/surgery
Humans ; Case-Control Studies ; Feasibility Studies ; Hepatectomy/adverse effects ; Hepatectomy/methods ; Liver/diagnostic imaging ; Liver/surgery ; Length of Stay ; Disease Progression ; Retrospective Studies ; Postoperative Complications/etiology ; Postoperative Complications/surgery
Czasopismo naukowe
Tytuł:
S100A9 monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function.
Autorzy:
Tu X; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.
Chen L; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.; The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, People's Republic of China.
Zheng Y; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Mu C; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.
Zhang Z; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.; College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, People's Republic of China.
Wang F; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.; The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, People's Republic of China.
Ren Y; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Duan Y; The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, People's Republic of China.
Zhang H; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Tong Z; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Liu L; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Sun X; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Zhao P; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Wang L; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310058, People's Republic of China.
Feng X; The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, People's Republic of China. .; Center for Life Sciences, Shaoxing Institute, Zhejiang University, Shaoxing, 321000, People's Republic of China. .
Fang W; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China. .
Liu X; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China. .; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 08; Vol. 43 (1), pp. 72. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/metabolism
Humans ; Animals ; Mice ; Monocytes/metabolism ; B7-H1 Antigen/metabolism ; T-Lymphocytes/metabolism ; Immunotherapy ; Tumor Microenvironment ; Calgranulin B/metabolism
Czasopismo naukowe
Tytuł:
ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis.
Autorzy:
Meng W; Department of Laboratory, Shenzhen Baoan Shiyan People's Hospital, No. 11, Jixiang Road, Shiyan Street, Baoan District, Shenzhen, Guangdong, 518108, P.R. China.
Lu X; Department of Laboratory, Shenzhen Baoan Shiyan People's Hospital, No. 11, Jixiang Road, Shiyan Street, Baoan District, Shenzhen, Guangdong, 518108, P.R. China.
Wang G; Department of Laboratory, Shenzhen Baoan Shiyan People's Hospital, No. 11, Jixiang Road, Shiyan Street, Baoan District, Shenzhen, Guangdong, 518108, P.R. China.
Xiao Q; Department of Blood Transfusion, Shenzhen Baoan Shiyan People's Hospital, Shenzhen, Guangdong, 518108, P.R. China.
Gao J; Department of Laboratory, Shenzhen Baoan Shiyan People's Hospital, No. 11, Jixiang Road, Shiyan Street, Baoan District, Shenzhen, Guangdong, 518108, P.R. China. .
Pokaż więcej
Źródło:
Functional & integrative genomics [Funct Integr Genomics] 2024 Mar 08; Vol. 24 (2), pp. 53. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/metabolism
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/metabolism
Liver Neoplasms*/pathology
Humans ; Cell Line, Tumor ; Hep G2 Cells ; Glycolysis ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Fructose-Bisphosphate Aldolase/genetics ; Fructose-Bisphosphate Aldolase/metabolism
Czasopismo naukowe
Tytuł:
An AgPd NP-based lateral flow immunoassay for simultaneous detection of glycocholic acid and alpha-fetoprotein.
Autorzy:
Jiang S; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Chen Y; Department of Laboratory Medicine, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Liang J; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Xiao H; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Lin M; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Cui X; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Zhao S; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Pokaż więcej
Źródło:
Analytical methods : advancing methods and applications [Anal Methods] 2024 Mar 07; Vol. 16 (10), pp. 1508-1514. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnosis
Liver Neoplasms*/pathology
Humans ; alpha-Fetoproteins ; Biomarkers, Tumor ; Glycocholic Acid ; Immunoassay/methods
Czasopismo naukowe
Tytuł:
Drug-Loaded Tumor-Derived Microparticles Elicit CD8+ T Cell-Mediated Anti-Tumor Response in Hepatocellular Carcinoma.
Autorzy:
Chen Y; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Zhang Y; Hubei Engineering Research Center of Tumor-Targeted Biochemotherapy, Wuhan, 430030, People's Republic of China.
Wang J; Department of Hepatobiliary Surgery, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, 621000, People's Republic of China.
Cai X; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Chen J; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Min X; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Xu Y; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Qin Q; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Wan C; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Pokaż więcej
Źródło:
International journal of nanomedicine [Int J Nanomedicine] 2024 Mar 06; Vol. 19, pp. 2227-2239. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Cancer Vaccines*
Humans ; Animals ; Mice ; Doxorubicin ; CD8-Positive T-Lymphocytes ; Tumor Microenvironment ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Sorafenib-Encapsulated Liposomes to Activate Hypoxia-Sensitive Tirapazamine for Synergistic Chemotherapy of Hepatocellular Carcinoma.
Autorzy:
Zhao J; Department of Surgery, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu 322000, China.
Dai W; MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310058, China.
Zhan L; MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310058, China.
Lei L; Department of Surgery, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu 322000, China.
Jin Q; MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310058, China.
Wang J; Department of Surgery, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu 322000, China.; Department of Colorectal Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Tang Z; Department of Surgery, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu 322000, China.; Department of Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Pokaż więcej
Źródło:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Mar 06; Vol. 16 (9), pp. 11289-11304. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/pathology
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Prodrugs*/pharmacology
Humans ; Tirapazamine/pharmacology ; Sorafenib/pharmacology ; Liposomes ; Hypoxia/drug therapy ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Liensinine, a Novel and Food-Derived Compound, Exerts Potent Antihepatoma Efficacy via Inhibiting the Kv10.1 Channel.
Autorzy:
Ma B; State Key Laboratory of Reliability and Intelligence of Electrical Equipment, Hebei University of Technology, Tianjin 300401, China.; Key Laboratory of Electromagnetic Field and Electrical Apparatus Reliability of Hebei Province, Hebei University of Technology, Tianjin 300401, China.; Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Sciences & Biomedical Engineering, Hebei University of Technology, Tianjin 300401, China.
Shi S; Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin 300072, China.
Guo W; Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Sciences & Biomedical Engineering, Hebei University of Technology, Tianjin 300401, China.
Zhang H; Department of Pharmacology, Hebei Medical University, Shijiazhuang 050017, China.
Zhao Z; Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Sciences & Biomedical Engineering, Hebei University of Technology, Tianjin 300401, China.
An H; State Key Laboratory of Reliability and Intelligence of Electrical Equipment, Hebei University of Technology, Tianjin 300401, China.; Key Laboratory of Electromagnetic Field and Electrical Apparatus Reliability of Hebei Province, Hebei University of Technology, Tianjin 300401, China.; Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Sciences & Biomedical Engineering, Hebei University of Technology, Tianjin 300401, China.
Pokaż więcej
Źródło:
Journal of agricultural and food chemistry [J Agric Food Chem] 2024 Mar 06; Vol. 72 (9), pp. 4689-4702. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Isoquinolines*
Phenols*
Humans ; Ether-A-Go-Go Potassium Channels/chemistry ; Ether-A-Go-Go Potassium Channels/metabolism ; Carcinogenesis/metabolism
Czasopismo naukowe
Tytuł:
Effect of surface modification on the distribution of magnetic nanorings in hepatocellular carcinoma and immune cells.
Autorzy:
Jiao W; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Wen N; School of Science and Chemical Engineering, Ningxia Institute of Science and Technology, Shizuishan, Ningxia 753000, China.
Wang S; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Zhou G; National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Province Center for Regenerative Medicine and Surgery Engineering Research, Shaanxi Provincial Key Laboratory of Magnetic Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. .; Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710049, China.
Lu Q; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Su Z; School of materials, Sun Yat-Sen University, Shen Zhen, Guangdong 529406, China.
Wang X; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Hu S; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Xie Y; Department of Hematology and Rheumatology, Qinghai Provincial People's Hospital, 2 Gonghe Road, Xining, Qinghai 810007, China.
Zhang N; National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Province Center for Regenerative Medicine and Surgery Engineering Research, Shaanxi Provincial Key Laboratory of Magnetic Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. .; Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710049, China.
Liu X; National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Province Center for Regenerative Medicine and Surgery Engineering Research, Shaanxi Provincial Key Laboratory of Magnetic Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. .; Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710049, China.; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Pokaż więcej
Źródło:
Journal of materials chemistry. B [J Mater Chem B] 2024 Mar 06; Vol. 12 (10), pp. 2628-2638. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/therapy
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/therapy
Liver Neoplasms*/pathology
Hyperthermia, Induced*/methods
Mice ; Animals ; Magnetics ; Magnetic Phenomena ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Transcriptomic screening of novel targets of sericin in human hepatocellular carcinoma cells.
Autorzy:
Jantaravinid J; Center of Excellence in Bioactive Resources for Innovative Clinical Applications, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok, 10330, Thailand.
Tirawanchai N; Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, 2, Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
Ampawong S; Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, 420/6, Ratchawithi Road, Ratchathewi, Bangkok, 10400, Thailand.
Kengkoom K; Research and Academic Support Office, National Laboratory Animal Center, Mahidol University, 999, Salaya, Puttamonthon, Nakorn Pathom, 73170, Thailand.
Somkasetrin A; Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, 2, Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
Nakhonsri V; National Biobank of Thailand (NBT), National Science and Technology Development Agency (NSTDA), 144 Innovation Cluster 2 Building (INC) Tower A, Thailand Science Park, Khlong Nueng, Khlong Luang District, Pathum Thani, 12120, Thailand.
Aramwit P; Center of Excellence in Bioactive Resources for Innovative Clinical Applications, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok, 10330, Thailand. .; The Academy of Science, The Royal Society of Thailand, Dusit, Bangkok, 10330, Thailand. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 05; Vol. 14 (1), pp. 5455. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Sericins*/pharmacology
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Humans ; TNF Receptor-Associated Factor 6 ; Gene Expression Profiling ; Apolipoproteins B
Czasopismo naukowe
Tytuł:
Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma.
Autorzy:
Zhao T; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Immunity and Targeted Therapy for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Wei P; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.; Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
Zhang C; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Zhou S; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Liang L; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Guo S; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Yin Z; The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, China.
Cheng S; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Gan Z; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Xia Y; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Zhang Y; Department of Oncology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Guo S; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Zhong J; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Yang Z; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Tu F; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Wang Q; Department of Gynecology, Xinxiang Central Hospital, Xinxiang, China.; The Fourth Clinical College, Xinxiang Medical University, Xinxiang, China.
Bai J; Department of Gynecology, Xinxiang Central Hospital, Xinxiang, China.; The Fourth Clinical College, Xinxiang Medical University, Xinxiang, China.
Ren F; Henan International Joint Laboratory of Immunity and Targeted Therapy for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Feng Z; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Jia H; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Pokaż więcej
Źródło:
ELife [Elife] 2024 Mar 05; Vol. 12. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/radiotherapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/radiotherapy
Nitrofurans*
Animals ; Mice ; B7-H1 Antigen ; Hydroxybenzoates
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies